Recent Updates
Recently added Catalysts
STAA Positive Sentiment

STAAR Surgical Names Former CEO David Bailey as Chief Commercial Officer

Key Takeaway: STAAR Surgical has appointed David Bailey as Chief Commercial Officer, who will be part of the executive committee and report to the CEO. Bailey's extensive knowledge of STAAR is anticipated to positively influence the company's commercial strategies and growth trajectory.

Market Sentiment Analysis

POSITIVE FACTORS

  • David Bailey's appointment is expected to enhance STAAR's commercial strategy.
  • Bailey has a strong understanding of STAAR's operations and vision.
  • His previous experience is likely to drive growth in the company.

Full Press Release Details

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company ("STAAR" or the "Company") (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced the appointment of David Bailey as Chief Commercial Officer. Mr. Bailey will join STAAR's executive committee and report to Warren Foust, President and Chief Executive Officer. "David Bailey doesn't just know STAAR, he helped change the trajectory of the entir

Frequently Asked Questions

Who has been appointed as the new CCO of STAAR Surgical?

David Bailey has been appointed as the Chief Commercial Officer of STAAR Surgical.

What is David Bailey's role at STAAR Surgical?

David Bailey will join the executive committee and report to the CEO.

What is STAAR Surgical known for?

STAAR Surgical is a global leader in phakic IOLs and vision correction.

How is David Bailey expected to impact STAAR?

His extensive knowledge is expected to enhance STAAR's commercial strategies.

Last updated: Sep 8, 2026